The client's father was a 78-year-old man with a common pattern: hypertension, atrial fibrillation, type 2 diabetes, and osteoarthritis. These had been managed across four separate consultants: a cardiologist, an endocrinologist, a rheumatologist, and his GP. He was on 11 medications across these different specialists. His family noticed increasing confusion, unusual forgetfulness, and occasional falls. A neurologist had been suggested. But no one had stepped back to ask whether the problem was neurological or pharmaceutical.
We collected his complete medication list and cross-referenced every interaction against current pharmacological databases. We reviewed dosing in the context of his age, renal function, and individual drug metabolism. We examined his symptom timeline against when medications had been added or changed.
We created a comprehensive medication interaction report documenting every potential interaction, rated by severity and evidence quality. We then prioritised the findings and presented them to his GP with specific recommendations.
The audit identified 3 significant interactions. Metformin and an ACE inhibitor combination was increasing his serum creatinine, narrowing his therapeutic window. His statin and one of his arthritis medications were competing for hepatic metabolism, potentially elevating statin levels. And his diuretic, combined with his diabetes medication, was creating recurrent hypokalemia, contributing to his confusion and falls.
We also identified 2 completely redundant prescriptions that had simply been continued from previous specialists without review.
His GP acted on the report immediately. He discontinued the redundant medications, adjusted doses on two others, and added potassium monitoring. Within 6 weeks, his confusion resolved. His fall risk decreased significantly. His cognitive function returned to normal.
Medication regimen reduced to 9 drugs with safer interactions. Confusion resolved within 6 weeks. Fall risk eliminated. Improved quality of life and medication safety profile. All changes implemented with GP oversight and patient safety monitoring.
All case studies are anonymised composites based on real scenarios. Details changed to protect confidentiality. Individual outcomes vary.
Is polypharmacy affecting your elderly parent's health?
Begin a Private Inquiry